Inhibition of the heat shock response by PI103 enhances the cytotoxicity of arsenic trioxide

• Published in: Toxicological sciences Vol. 128; no. 1; pp. 126 - 136
• Main Authors: Yih, Ling-Huei, Hsu, Nai-Chi, Kuo, Hsiao-Hui, Wu, Yi-Chen
• Format: Journal Article
• Language: English
• Published: United States 01.07.2012
• Subjects: Arsenicals; Base Sequence; Blotting, Western; Cells, Cultured; DNA Primers; DNA-Binding Proteins - metabolism; Electrophoretic Mobility Shift Assay; Furans - pharmacology; Heat Shock Transcription Factors; Heat-Shock Proteins - antagonists & inhibitors; Heat-Shock Proteins - metabolism; Heat-Shock Response; Humans; Oxides - toxicity; Phosphorylation; Polymerase Chain Reaction; Pyridines - pharmacology; Pyrimidines - pharmacology; Transcription Factors - metabolism; Transcriptional Activation
• ISSN: 1096-6080; 1096-0929
• DOI: 10.1093/toxsci/kfs130

Heat shock factor 1 (HSF1) is a key regulator of the cytoprotective and anti-apoptotic heat shock response and can be activated by arsenite. Inhibition of HSF1 activation may therefore enhance the cytotoxicity of arsenic trioxide (ATO). We show that ATO induced HSF1 phosphorylation at serine 326 (S326) and induced HSF1-dependent expression of heat shock proteins (HSPs) 27 and 70 in cultured cells. HSF1 significantly reduced cell sensitivity to ATO by reducing apoptosis. Disruption of HSF1 function not only reduced ATO induction of HSP27 and 70 but also enhanced ATO cytotoxicity by elevating apoptosis. These results reveal that HSF1 activation and the resulting induction of HSPs may protect cells from ATO cytotoxicity. The diminished expression of HSPs and hypersensitivity to ATO in cells stably depleted of HSF1 was rescued by ectopic expression of wild-type HSF1 but not an S326A substitution mutant, indicating that phosphorylation at S326 was critical for the protective effect of HSF1. Simultaneous treatment of cells with ATO and PI103, an inhibitor of members of the phosphatidylinositol 3-kinase (PI3K) family, suppressed not only ATO-induced expression of an HSP70 promoter-reporter construct and endogenous HSP70 but also phosphorylation of HSF1 S326. PI103 considerably reduced HSF1 transactivation in ATO-treated cells but had only a limited effect on HSF1 nuclear translocation and DNA binding. Furthermore, PI103 enhanced ATO cytotoxicity in an HSF1-dependent manner. Thus, inhibition of S326 phosphorylation by PI103 blocks the transactivation of HSF1 and may consequently suppress ATO induction of the heat shock response and sensitize cells to ATO.